Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …

Background Dabigatran etexilate, a new thrombin inhibitor, has been shown to be
comparable to warfarin in patients with atrial fibrillation (AF). However, there is a limited …

Dabigatran versus Warfarin for AF Ablation Background Uninterrupted oral anticoagulant
(OA) therapy with warfarin has become the standard of care at many centers performing …

Objectives: The purpose of this study was to evaluate the feasibility and safety of
periprocedural dabigatran during atrial fibrillation (AF) ablation. Background: AF ablation …

Background We aimed to evaluate the feasibility of an oral direct thrombin inhibitor,
dabigatran, as a periprocedural anticoagulant for use with ablation of atrial fibrillation (AF) …

Background: Periprocedural anticoagulation using uninterrupted warfarin could reduce the
risk of thromboembolic complications of atrial fibrillation (AF) ablation. Few studies, however …

Aims To summarize and analyse the published literature on the efficacy and safety of
dabigatran for anticoagulation during atrial fibrillation (AF) ablation. Methods and results A …

Dabigatran After AF Ablation. Introduction: Atrial fibrillation (AF) ablation requires
postprocedural anticoagulation to prevent thromboembolic events because of the ablation …

Background—Pulmonary vein isolation (PVI) for atrial fibrillation is associated with a
transient increased risk of thromboembolic and hemorrhagic events. We hypothesized that …

BACKGROUND: It is not clear whether dabigatran is as safe and effective as uninterrupted
anticoagulation with warfarin during radiofrequency catheter ablation (RFA) of atrial …